Rank | Gene Set | Z-score |
---|---|---|
1 | viral transcription (GO:0019083) | 6.43746219 |
2 | ribosomal small subunit assembly (GO:0000028) | 6.41426625 |
3 | translational termination (GO:0006415) | 6.21395834 |
4 | ribosomal small subunit biogenesis (GO:0042274) | 5.81668933 |
5 | DNA deamination (GO:0045006) | 5.54573186 |
6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.49301410 |
7 | cotranslational protein targeting to membrane (GO:0006613) | 5.40744885 |
8 | protein targeting to ER (GO:0045047) | 5.38578562 |
9 | translational elongation (GO:0006414) | 5.38306742 |
10 | protein localization to endoplasmic reticulum (GO:0070972) | 5.12833225 |
11 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.09154402 |
12 | ribosomal large subunit biogenesis (GO:0042273) | 5.01160086 |
13 | viral life cycle (GO:0019058) | 4.99301981 |
14 | cellular protein complex disassembly (GO:0043624) | 4.91775647 |
15 | translational initiation (GO:0006413) | 4.73974361 |
16 | * pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.70133084 |
17 | GDP-mannose metabolic process (GO:0019673) | 4.68499381 |
18 | maturation of SSU-rRNA (GO:0030490) | 4.63862372 |
19 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.57640782 |
20 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.36473294 |
21 | ATP synthesis coupled proton transport (GO:0015986) | 4.16410253 |
22 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.16410253 |
23 | proteasome assembly (GO:0043248) | 4.15301371 |
24 | protein complex disassembly (GO:0043241) | 4.13533418 |
25 | translation (GO:0006412) | 4.06592037 |
26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.99091983 |
27 | macromolecular complex disassembly (GO:0032984) | 3.92682834 |
28 | base-excision repair, AP site formation (GO:0006285) | 3.91774539 |
29 | sequestering of actin monomers (GO:0042989) | 3.90884470 |
30 | * deoxyribonucleotide catabolic process (GO:0009264) | 3.90537688 |
31 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.89625541 |
32 | iron-sulfur cluster assembly (GO:0016226) | 3.87018654 |
33 | metallo-sulfur cluster assembly (GO:0031163) | 3.87018654 |
34 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.80777338 |
35 | * deoxyribose phosphate catabolic process (GO:0046386) | 3.75141643 |
36 | * pyrimidine nucleotide catabolic process (GO:0006244) | 3.73659183 |
37 | * pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.73487383 |
38 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.71807900 |
39 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.66582863 |
40 | protein targeting to membrane (GO:0006612) | 3.63490253 |
41 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.55406532 |
42 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.55346627 |
43 | nucleotide salvage (GO:0043173) | 3.54368532 |
44 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.48450628 |
45 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.48450628 |
46 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.48338320 |
47 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.47944384 |
48 | negative regulation of ligase activity (GO:0051352) | 3.47944384 |
49 | UTP biosynthetic process (GO:0006228) | 3.45833763 |
50 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.45791230 |
51 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.45791230 |
52 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.45791230 |
53 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.43867850 |
54 | pseudouridine synthesis (GO:0001522) | 3.41601057 |
55 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.41044718 |
56 | purine nucleotide salvage (GO:0032261) | 3.36070654 |
57 | negative regulation of B cell apoptotic process (GO:0002903) | 3.34093547 |
58 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.32953910 |
59 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.32953910 |
60 | formation of translation preinitiation complex (GO:0001731) | 3.32053600 |
61 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.31556992 |
62 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.30147418 |
63 | termination of RNA polymerase III transcription (GO:0006386) | 3.30147418 |
64 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.30083719 |
65 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.30083719 |
66 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.28573066 |
67 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.27357603 |
68 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.26770316 |
69 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.24527364 |
70 | cellular component biogenesis (GO:0044085) | 3.23109116 |
71 | protein maturation by protein folding (GO:0022417) | 3.22610042 |
72 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.20454856 |
73 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.19526593 |
74 | UTP metabolic process (GO:0046051) | 3.18977908 |
75 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.18525123 |
76 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.18525123 |
77 | UV protection (GO:0009650) | 3.15743232 |
78 | respiratory electron transport chain (GO:0022904) | 3.14778662 |
79 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.13386326 |
80 | pentose metabolic process (GO:0019321) | 3.13181604 |
81 | CTP biosynthetic process (GO:0006241) | 3.12917003 |
82 | CTP metabolic process (GO:0046036) | 3.12917003 |
83 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.12296252 |
84 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.12296252 |
85 | establishment of viral latency (GO:0019043) | 3.11876222 |
86 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.11025619 |
87 | electron transport chain (GO:0022900) | 3.10095938 |
88 | mRNA catabolic process (GO:0006402) | 3.08955940 |
89 | rRNA processing (GO:0006364) | 3.07605934 |
90 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.07336647 |
91 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.07264048 |
92 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05715485 |
93 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.04097344 |
94 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.02912599 |
95 | protein neddylation (GO:0045116) | 3.01083023 |
96 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.00558590 |
97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.00485142 |
98 | oxidative phosphorylation (GO:0006119) | 2.99680704 |
99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.99612459 |
100 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.99534168 |
101 | histone arginine methylation (GO:0034969) | 2.99103495 |
102 | protein targeting to mitochondrion (GO:0006626) | 2.97836129 |
103 | rRNA metabolic process (GO:0016072) | 2.96641972 |
104 | mitochondrial calcium ion transport (GO:0006851) | 2.93586579 |
105 | rRNA modification (GO:0000154) | 2.92444835 |
106 | * deoxyribose phosphate metabolic process (GO:0019692) | 2.91483733 |
107 | establishment of protein localization to mitochondrion (GO:0072655) | 2.90943304 |
108 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.89574287 |
109 | ribosome biogenesis (GO:0042254) | 2.88372454 |
110 | RNA catabolic process (GO:0006401) | 2.88056177 |
111 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.87748629 |
112 | NADH dehydrogenase complex assembly (GO:0010257) | 2.87748629 |
113 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.87748629 |
114 | protein complex biogenesis (GO:0070271) | 2.86229253 |
115 | cellular response to interferon-beta (GO:0035458) | 2.85852688 |
116 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.84636961 |
117 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.82350343 |
118 | NIK/NF-kappaB signaling (GO:0038061) | 2.81761161 |
119 | proline biosynthetic process (GO:0006561) | 2.81281628 |
120 | DNA strand elongation (GO:0022616) | 2.80918199 |
121 | positive regulation of cell cycle arrest (GO:0071158) | 2.78742152 |
122 | respiratory chain complex IV assembly (GO:0008535) | 2.77171865 |
123 | positive regulation of ligase activity (GO:0051351) | 2.76033261 |
124 | chaperone-mediated protein transport (GO:0072321) | 2.75686683 |
125 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.74366680 |
126 | pentose-phosphate shunt (GO:0006098) | 2.74309579 |
127 | response to interferon-beta (GO:0035456) | 2.73838454 |
128 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.71928631 |
129 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.71112811 |
130 | regulation of mitochondrial translation (GO:0070129) | 2.70327345 |
131 | heme biosynthetic process (GO:0006783) | 2.70052145 |
132 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.69996790 |
133 | protein localization to mitochondrion (GO:0070585) | 2.69195530 |
134 | 7-methylguanosine mRNA capping (GO:0006370) | 2.67069633 |
135 | rRNA transcription (GO:0009303) | 2.66965267 |
136 | nucleoside salvage (GO:0043174) | 2.66148260 |
137 | regulation of cellular amine metabolic process (GO:0033238) | 2.66070324 |
138 | peptidyl-arginine methylation (GO:0018216) | 2.65759318 |
139 | peptidyl-arginine N-methylation (GO:0035246) | 2.65759318 |
140 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.65683280 |
141 | regulation of protein heterodimerization activity (GO:0043497) | 2.63883984 |
142 | cytochrome complex assembly (GO:0017004) | 2.62602656 |
143 | peptidyl-histidine modification (GO:0018202) | 2.62461570 |
144 | base-excision repair (GO:0006284) | 2.62385837 |
145 | GTP biosynthetic process (GO:0006183) | 2.60051292 |
146 | 7-methylguanosine RNA capping (GO:0009452) | 2.59101129 |
147 | RNA capping (GO:0036260) | 2.59101129 |
148 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.59058649 |
149 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.57582239 |
150 | establishment of protein localization to membrane (GO:0090150) | 2.57290943 |
151 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.56262074 |
152 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.56111942 |
153 | protein targeting (GO:0006605) | 2.55207660 |
154 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.53929666 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.12544647 |
2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.04996348 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.72574297 |
4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.62097776 |
5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.51386920 |
6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.43359794 |
7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.34177590 |
8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.22310304 |
9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.16073193 |
10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.12761867 |
11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82970181 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.74093941 |
13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.73247784 |
14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.67149540 |
15 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.65276814 |
16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.63980520 |
17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.48269221 |
18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.46723729 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45874547 |
20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38007548 |
21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.34388157 |
22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.31357889 |
23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.27699373 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25499908 |
25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25048418 |
26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.22171865 |
27 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.18807912 |
28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.13975194 |
29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12471201 |
30 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10012098 |
31 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.08274190 |
32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.01771112 |
33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.95384434 |
34 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.94239087 |
35 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.94207492 |
36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87228815 |
37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.82584999 |
38 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.80025047 |
39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.79791112 |
40 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.78106041 |
41 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.75745689 |
42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74368357 |
43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.74360051 |
44 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.74157489 |
45 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73773848 |
46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.73593943 |
47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72370402 |
48 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.71647707 |
49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.69187094 |
50 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.65373460 |
51 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.65261416 |
52 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.62582699 |
53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62050926 |
54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.61026123 |
55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60103341 |
56 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.58824412 |
57 | P68_20966046_ChIP-Seq_HELA_Human | 1.56772646 |
58 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.54986565 |
59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.54908326 |
60 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.53985489 |
61 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.52022547 |
62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47939079 |
63 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47542786 |
64 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.46497926 |
65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43765744 |
66 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.43694770 |
67 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.42701217 |
68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41588041 |
69 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.41442980 |
70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38282481 |
71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.37175367 |
72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.36669287 |
73 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32746426 |
74 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.28536306 |
75 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.27104584 |
76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24384675 |
77 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24017468 |
78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21697878 |
79 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21695085 |
80 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21140210 |
81 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.20978487 |
82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20596592 |
83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18302077 |
84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18282020 |
85 | MYC_22102868_ChIP-Seq_BL_Human | 1.18204951 |
86 | MYB_26560356_Chip-Seq_TH2_Human | 1.16997410 |
87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16752029 |
88 | MAF_26560356_Chip-Seq_TH1_Human | 1.16642029 |
89 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.15861232 |
90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14997175 |
91 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.13880131 |
92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13744242 |
93 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13091564 |
94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11632141 |
95 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10051246 |
96 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.09651868 |
97 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09146153 |
98 | * MAF_26560356_Chip-Seq_TH2_Human | 1.08182545 |
99 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.07921461 |
100 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.07852778 |
101 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07548203 |
102 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06179740 |
103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05472512 |
104 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05297848 |
105 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04111652 |
106 | MYB_26560356_Chip-Seq_TH1_Human | 1.03273123 |
107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02810026 |
108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02268335 |
109 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02205043 |
110 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02120272 |
111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01828519 |
112 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01189712 |
113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01079973 |
114 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00989886 |
115 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99985773 |
116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99741608 |
117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98218538 |
118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96970058 |
119 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96066000 |
120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93895941 |
121 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93468717 |
122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93137716 |
123 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.91291037 |
124 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91124627 |
125 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91082693 |
126 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89665195 |
127 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89619179 |
128 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89525343 |
129 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89233623 |
130 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88810086 |
131 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87985927 |
132 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.87852903 |
133 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87565212 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.76380413 |
2 | MP0005671_abnormal_response_to | 3.32358623 |
3 | MP0009379_abnormal_foot_pigmentation | 3.31896628 |
4 | MP0003763_abnormal_thymus_physiology | 3.25028140 |
5 | MP0009785_altered_susceptibility_to | 3.22454603 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.15190264 |
7 | MP0005451_abnormal_body_composition | 3.08117484 |
8 | MP0002148_abnormal_hypersensitivity_rea | 2.97239787 |
9 | MP0000685_abnormal_immune_system | 2.92486907 |
10 | MP0003436_decreased_susceptibility_to | 2.79939265 |
11 | MP0003693_abnormal_embryo_hatching | 2.76253914 |
12 | MP0005000_abnormal_immune_tolerance | 2.69561880 |
13 | MP0001800_abnormal_humoral_immune | 2.63909236 |
14 | MP0005025_abnormal_response_to | 2.62207738 |
15 | MP0009278_abnormal_bone_marrow | 2.59340789 |
16 | MP0009333_abnormal_splenocyte_physiolog | 2.56198060 |
17 | MP0005387_immune_system_phenotype | 2.55486446 |
18 | MP0001790_abnormal_immune_system | 2.55486446 |
19 | MP0002166_altered_tumor_susceptibility | 2.42531610 |
20 | MP0002723_abnormal_immune_serum | 2.41997997 |
21 | MP0002420_abnormal_adaptive_immunity | 2.40825677 |
22 | MP0001819_abnormal_immune_cell | 2.40124227 |
23 | MP0002452_abnormal_antigen_presenting | 2.37464109 |
24 | MP0002006_tumorigenesis | 2.32232857 |
25 | MP0004957_abnormal_blastocyst_morpholog | 2.22469787 |
26 | MP0003724_increased_susceptibility_to | 2.21484038 |
27 | MP0003866_abnormal_defecation | 2.20416188 |
28 | MP0010155_abnormal_intestine_physiology | 2.20348710 |
29 | MP0002398_abnormal_bone_marrow | 2.16698056 |
30 | MP0002405_respiratory_system_inflammati | 1.99183484 |
31 | MP0000716_abnormal_immune_system | 1.98472776 |
32 | MP0002419_abnormal_innate_immunity | 1.98128687 |
33 | MP0002396_abnormal_hematopoietic_system | 1.94293001 |
34 | MP0001873_stomach_inflammation | 1.90949901 |
35 | MP0000490_abnormal_crypts_of | 1.89994343 |
36 | MP0002722_abnormal_immune_system | 1.89060183 |
37 | MP0000689_abnormal_spleen_morphology | 1.81936377 |
38 | MP0001853_heart_inflammation | 1.79233340 |
39 | MP0002429_abnormal_blood_cell | 1.75274122 |
40 | MP0008260_abnormal_autophagy | 1.72349098 |
41 | MP0005083_abnormal_biliary_tract | 1.72103676 |
42 | MP0001845_abnormal_inflammatory_respons | 1.69074090 |
43 | MP0000858_altered_metastatic_potential | 1.66569946 |
44 | MP0006082_CNS_inflammation | 1.60714711 |
45 | MP0003186_abnormal_redox_activity | 1.60002312 |
46 | MP0005075_abnormal_melanosome_morpholog | 1.56124486 |
47 | MP0000703_abnormal_thymus_morphology | 1.49709179 |
48 | MP0002132_abnormal_respiratory_system | 1.46470480 |
49 | MP0003077_abnormal_cell_cycle | 1.46210898 |
50 | MP0004147_increased_porphyrin_level | 1.43337717 |
51 | MP0005464_abnormal_platelet_physiology | 1.43062197 |
52 | MP0002736_abnormal_nociception_after | 1.43060778 |
53 | MP0001661_extended_life_span | 1.42535500 |
54 | MP0004858_abnormal_nervous_system | 1.39937872 |
55 | MP0008469_abnormal_protein_level | 1.36692117 |
56 | MP0002163_abnormal_gland_morphology | 1.34643173 |
57 | MP0000678_abnormal_parathyroid_gland | 1.34005441 |
58 | MP0004947_skin_inflammation | 1.33591609 |
59 | MP0004185_abnormal_adipocyte_glucose | 1.33399117 |
60 | MP0005360_urolithiasis | 1.32102340 |
61 | MP0001545_abnormal_hematopoietic_system | 1.31234731 |
62 | MP0005397_hematopoietic_system_phenotyp | 1.31234731 |
63 | MP0002933_joint_inflammation | 1.29594477 |
64 | MP0004808_abnormal_hematopoietic_stem | 1.28932830 |
65 | MP0009840_abnormal_foam_cell | 1.27408565 |
66 | MP0005174_abnormal_tail_pigmentation | 1.26635381 |
67 | MP0003300_gastrointestinal_ulcer | 1.24571563 |
68 | MP0001663_abnormal_digestive_system | 1.24538077 |
69 | MP0001533_abnormal_skeleton_physiology | 1.20422503 |
70 | MP0005310_abnormal_salivary_gland | 1.17311160 |
71 | MP0002019_abnormal_tumor_incidence | 1.13743463 |
72 | MP0002009_preneoplasia | 1.13067615 |
73 | MP0005330_cardiomyopathy | 1.06534081 |
74 | MP0010094_abnormal_chromosome_stability | 1.05202867 |
75 | MP0008932_abnormal_embryonic_tissue | 1.03940505 |
76 | MP0003786_premature_aging | 1.03894336 |
77 | MP0008057_abnormal_DNA_replication | 1.03477609 |
78 | MP0000372_irregular_coat_pigmentation | 1.02600001 |
79 | MP0008789_abnormal_olfactory_epithelium | 1.02272938 |
80 | MP0006035_abnormal_mitochondrial_morpho | 1.01885217 |
81 | MP0003303_peritoneal_inflammation | 0.99797163 |
82 | MP0003718_maternal_effect | 0.99599924 |
83 | MP0001764_abnormal_homeostasis | 0.99530908 |
84 | MP0004510_myositis | 0.97806922 |
85 | MP0002277_abnormal_respiratory_mucosa | 0.97035331 |
86 | MP0003191_abnormal_cellular_cholesterol | 0.96407073 |
87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95938325 |
88 | MP0008007_abnormal_cellular_replicative | 0.95403624 |
89 | MP0000358_abnormal_cell_content/ | 0.93306408 |
90 | MP0000465_gastrointestinal_hemorrhage | 0.90972659 |
91 | MP0001968_abnormal_touch/_nociception | 0.90120058 |
92 | MP0001986_abnormal_taste_sensitivity | 0.89738028 |
93 | MP0000350_abnormal_cell_proliferation | 0.89627731 |
94 | MP0006036_abnormal_mitochondrial_physio | 0.89037894 |
95 | MP0003111_abnormal_nucleus_morphology | 0.88972399 |
96 | MP0005084_abnormal_gallbladder_morpholo | 0.88266646 |
97 | MP0003448_altered_tumor_morphology | 0.87502059 |
98 | MP0000750_abnormal_muscle_regeneration | 0.87170628 |
99 | MP0009643_abnormal_urine_homeostasis | 0.87016934 |
100 | MP0000015_abnormal_ear_pigmentation | 0.86994083 |
101 | MP0002653_abnormal_ependyma_morphology | 0.86456553 |
102 | MP0003315_abnormal_perineum_morphology | 0.85933647 |
103 | MP0008058_abnormal_DNA_repair | 0.85320776 |
104 | MP0000681_abnormal_thyroid_gland | 0.85275342 |
105 | MP0001730_embryonic_growth_arrest | 0.84988274 |
106 | MP0000477_abnormal_intestine_morphology | 0.84941570 |
107 | MP0001727_abnormal_embryo_implantation | 0.83402030 |
108 | MP0000313_abnormal_cell_death | 0.81620305 |
109 | MP0002638_abnormal_pupillary_reflex | 0.81487632 |
110 | MP0000003_abnormal_adipose_tissue | 0.81453952 |
111 | MP0005381_digestive/alimentary_phenotyp | 0.80174556 |
112 | MP0002095_abnormal_skin_pigmentation | 0.80028455 |
113 | MP0006292_abnormal_olfactory_placode | 0.76288104 |
114 | MP0009763_increased_sensitivity_to | 0.76199136 |
115 | MP0005377_hearing/vestibular/ear_phenot | 0.74833751 |
116 | MP0003878_abnormal_ear_physiology | 0.74833751 |
117 | MP0009764_decreased_sensitivity_to | 0.74272485 |
118 | MP0005501_abnormal_skin_physiology | 0.74157235 |
119 | MP0004381_abnormal_hair_follicle | 0.73877253 |
120 | MP0005332_abnormal_amino_acid | 0.73456824 |
121 | MP0006054_spinal_hemorrhage | 0.68484354 |
122 | MP0005058_abnormal_lysosome_morphology | 0.68225588 |
123 | MP0002080_prenatal_lethality | 0.67735075 |
124 | MP0005379_endocrine/exocrine_gland_phen | 0.65446990 |
125 | MP0005636_abnormal_mineral_homeostasis | 0.64203089 |
126 | MP0003656_abnormal_erythrocyte_physiolo | 0.63386988 |
127 | MP0001905_abnormal_dopamine_level | 0.63268560 |
128 | MP0001243_abnormal_dermal_layer | 0.62313219 |
129 | MP0000343_altered_response_to | 0.61941860 |
130 | MP0001348_abnormal_lacrimal_gland | 0.61193777 |
131 | MP0008872_abnormal_physiological_respon | 0.61190699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.96723617 |
2 | Abnormal number of erythroid precursors (HP:0012131) | 5.22150442 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.37355234 |
4 | Mitochondrial inheritance (HP:0001427) | 4.24493439 |
5 | Hepatocellular necrosis (HP:0001404) | 4.13681523 |
6 | Reticulocytopenia (HP:0001896) | 3.98021702 |
7 | Macrocytic anemia (HP:0001972) | 3.95745594 |
8 | Acute necrotizing encephalopathy (HP:0006965) | 3.87629784 |
9 | Increased hepatocellular lipid droplets (HP:0006565) | 3.84465975 |
10 | IgM deficiency (HP:0002850) | 3.84270263 |
11 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.78870197 |
12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.72828786 |
13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.72828786 |
14 | Pallor (HP:0000980) | 3.67415106 |
15 | Increased CSF lactate (HP:0002490) | 3.67401257 |
16 | Exertional dyspnea (HP:0002875) | 3.60697291 |
17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.54051967 |
18 | Hepatic necrosis (HP:0002605) | 3.53059869 |
19 | Petechiae (HP:0000967) | 3.43456546 |
20 | Recurrent abscess formation (HP:0002722) | 3.39546024 |
21 | Lipid accumulation in hepatocytes (HP:0006561) | 3.35963363 |
22 | Ragged-red muscle fibers (HP:0003200) | 3.30644445 |
23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.26786661 |
24 | Thrombocytosis (HP:0001894) | 3.12998228 |
25 | Microvesicular hepatic steatosis (HP:0001414) | 3.09557039 |
26 | Eczematoid dermatitis (HP:0000976) | 3.03871825 |
27 | Progressive macrocephaly (HP:0004481) | 3.01479814 |
28 | Renal Fanconi syndrome (HP:0001994) | 3.01254151 |
29 | Acute encephalopathy (HP:0006846) | 2.92263905 |
30 | Recurrent bacterial skin infections (HP:0005406) | 2.90725382 |
31 | Progressive muscle weakness (HP:0003323) | 2.88252101 |
32 | Testicular atrophy (HP:0000029) | 2.86858688 |
33 | Rough bone trabeculation (HP:0100670) | 2.86479376 |
34 | Increased intramyocellular lipid droplets (HP:0012240) | 2.85758049 |
35 | 3-Methylglutaconic aciduria (HP:0003535) | 2.85735019 |
36 | Increased serum lactate (HP:0002151) | 2.85001909 |
37 | Hypertensive crisis (HP:0100735) | 2.84832753 |
38 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82871416 |
39 | Dicarboxylic aciduria (HP:0003215) | 2.82871416 |
40 | Myositis (HP:0100614) | 2.82777268 |
41 | Chronic otitis media (HP:0000389) | 2.81813653 |
42 | IgG deficiency (HP:0004315) | 2.81243607 |
43 | Recurrent bronchitis (HP:0002837) | 2.73736566 |
44 | Pustule (HP:0200039) | 2.72078030 |
45 | Respiratory difficulties (HP:0002880) | 2.71023572 |
46 | Increased IgM level (HP:0003496) | 2.63149012 |
47 | Recurrent fungal infections (HP:0002841) | 2.53917612 |
48 | Obstructive lung disease (HP:0006536) | 2.53749729 |
49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53749729 |
50 | Abnormality of T cells (HP:0002843) | 2.53485853 |
51 | Respiratory failure (HP:0002878) | 2.53459286 |
52 | Lactic acidosis (HP:0003128) | 2.51471837 |
53 | Severe combined immunodeficiency (HP:0004430) | 2.46352554 |
54 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.46269967 |
55 | Abnormality of T cell physiology (HP:0011840) | 2.45267967 |
56 | Cellulitis (HP:0100658) | 2.43565688 |
57 | Hypergammaglobulinemia (HP:0010702) | 2.41945037 |
58 | Aplastic anemia (HP:0001915) | 2.41932874 |
59 | Increased muscle lipid content (HP:0009058) | 2.41405073 |
60 | Hepatosplenomegaly (HP:0001433) | 2.40334449 |
61 | Cerebral palsy (HP:0100021) | 2.39808390 |
62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.39379854 |
63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.39379854 |
64 | Mediastinal lymphadenopathy (HP:0100721) | 2.36785606 |
65 | Abnormality of macrophages (HP:0004311) | 2.35682559 |
66 | Exercise intolerance (HP:0003546) | 2.34795482 |
67 | Abnormality of T cell number (HP:0011839) | 2.34108559 |
68 | Abnormal trabecular bone morphology (HP:0100671) | 2.33788063 |
69 | Broad distal phalanx of finger (HP:0009836) | 2.33517591 |
70 | Recurrent viral infections (HP:0004429) | 2.31745867 |
71 | Reduced antithrombin III activity (HP:0001976) | 2.30770207 |
72 | Recurrent skin infections (HP:0001581) | 2.30444642 |
73 | Combined immunodeficiency (HP:0005387) | 2.30206035 |
74 | Abnormal glycosylation (HP:0012345) | 2.29624302 |
75 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.29624302 |
76 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.29624302 |
77 | Abnormal protein glycosylation (HP:0012346) | 2.29624302 |
78 | Pancytopenia (HP:0001876) | 2.28010705 |
79 | Panhypogammaglobulinemia (HP:0003139) | 2.26243206 |
80 | T lymphocytopenia (HP:0005403) | 2.22794570 |
81 | Multiple enchondromatosis (HP:0005701) | 2.21279462 |
82 | Muscle fiber atrophy (HP:0100295) | 2.20938909 |
83 | Progressive microcephaly (HP:0000253) | 2.20824069 |
84 | Meningitis (HP:0001287) | 2.20699899 |
85 | Myopathic facies (HP:0002058) | 2.19951502 |
86 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.19246813 |
87 | Increased serum ferritin (HP:0003281) | 2.18349380 |
88 | Abnormality of reticulocytes (HP:0004312) | 2.16094630 |
89 | Colitis (HP:0002583) | 2.14587879 |
90 | Type I transferrin isoform profile (HP:0003642) | 2.14218612 |
91 | Abnormal hemoglobin (HP:0011902) | 2.11956758 |
92 | Vasculitis (HP:0002633) | 2.11496385 |
93 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.11299937 |
94 | Villous atrophy (HP:0011473) | 2.11299937 |
95 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.10740404 |
96 | Agammaglobulinemia (HP:0004432) | 2.07452825 |
97 | Microretrognathia (HP:0000308) | 2.05820030 |
98 | Gastrointestinal inflammation (HP:0004386) | 2.05732676 |
99 | Prolonged neonatal jaundice (HP:0006579) | 2.05461826 |
100 | Vacuolated lymphocytes (HP:0001922) | 2.04925580 |
101 | Trismus (HP:0000211) | 2.03966395 |
102 | Stomatitis (HP:0010280) | 2.03582167 |
103 | Poikiloderma (HP:0001029) | 2.03495421 |
104 | Purpura (HP:0000979) | 2.03034604 |
105 | Premature ovarian failure (HP:0008209) | 2.02941201 |
106 | Nasal polyposis (HP:0100582) | 2.00535212 |
107 | Recurrent sinusitis (HP:0011108) | 2.00313962 |
108 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99988531 |
109 | Abnormality of eosinophils (HP:0001879) | 1.98310145 |
110 | Abnormal gallbladder physiology (HP:0012438) | 1.98025425 |
111 | Cholecystitis (HP:0001082) | 1.98025425 |
112 | Erythema (HP:0010783) | 1.98017724 |
113 | Rhabdomyolysis (HP:0003201) | 1.97917148 |
114 | Basal ganglia calcification (HP:0002135) | 1.95748717 |
115 | Urticaria (HP:0001025) | 1.95631007 |
116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94074405 |
117 | Granulocytopenia (HP:0001913) | 1.93977631 |
118 | B lymphocytopenia (HP:0010976) | 1.93710481 |
119 | Abnormality of B cell number (HP:0010975) | 1.93710481 |
120 | Poor head control (HP:0002421) | 1.93447824 |
121 | Lymphopenia (HP:0001888) | 1.93382840 |
122 | Neutropenia (HP:0001875) | 1.92571173 |
123 | Autoimmune hemolytic anemia (HP:0001890) | 1.92149604 |
124 | Emotional lability (HP:0000712) | 1.91831279 |
125 | Chronic sinusitis (HP:0011109) | 1.90072317 |
126 | Eosinophilia (HP:0001880) | 1.89400365 |
127 | Lymphoma (HP:0002665) | 1.88870163 |
128 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.88143826 |
129 | CNS demyelination (HP:0007305) | 1.87728705 |
130 | Encephalitis (HP:0002383) | 1.87626863 |
131 | Premature graying of hair (HP:0002216) | 1.87469212 |
132 | Abnormality of renal resorption (HP:0011038) | 1.87166635 |
133 | Abnormality of the umbilical cord (HP:0010881) | 1.85452430 |
134 | Lethargy (HP:0001254) | 1.84570709 |
135 | Cerebral edema (HP:0002181) | 1.83548904 |
136 | Cheilitis (HP:0100825) | 1.83541380 |
137 | Autoimmune thrombocytopenia (HP:0001973) | 1.82307690 |
138 | Seborrheic dermatitis (HP:0001051) | 1.77637907 |
139 | Death in infancy (HP:0001522) | 1.74727292 |
140 | Inflammation of the large intestine (HP:0002037) | 1.74524248 |
141 | Vertebral compression fractures (HP:0002953) | 1.74509411 |
142 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.73578729 |
143 | Single umbilical artery (HP:0001195) | 1.73578729 |
144 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.73578729 |
145 | Acute hepatic failure (HP:0006554) | 1.72975768 |
146 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.72224929 |
147 | Progressive external ophthalmoplegia (HP:0000590) | 1.71401486 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 5.04721053 |
2 | VRK2 | 4.33559821 |
3 | BCKDK | 4.19535151 |
4 | MST4 | 3.48739300 |
5 | PIM2 | 3.38851502 |
6 | ERN1 | 3.26121806 |
7 | MAP3K12 | 3.15145481 |
8 | STK16 | 3.11862659 |
9 | MAP4K1 | 2.99726977 |
10 | BUB1 | 2.77314473 |
11 | TESK2 | 2.70911493 |
12 | ARAF | 2.24554515 |
13 | TEC | 2.20665984 |
14 | BLK | 2.15625348 |
15 | TXK | 2.10213720 |
16 | KDR | 2.02272399 |
17 | EIF2AK1 | 1.98352490 |
18 | ZAP70 | 1.94253573 |
19 | TBK1 | 1.93832383 |
20 | TYK2 | 1.78729776 |
21 | KIT | 1.78065026 |
22 | SMG1 | 1.77211967 |
23 | RAF1 | 1.64772154 |
24 | NUAK1 | 1.62701011 |
25 | TESK1 | 1.57751813 |
26 | EIF2AK3 | 1.56414678 |
27 | TLK1 | 1.55264232 |
28 | ILK | 1.53803226 |
29 | WEE1 | 1.47224788 |
30 | NME1 | 1.43035366 |
31 | SYK | 1.40832377 |
32 | MAP3K14 | 1.40085818 |
33 | IKBKE | 1.38258512 |
34 | TAOK2 | 1.35004167 |
35 | IRAK4 | 1.33501520 |
36 | GRK6 | 1.33205510 |
37 | LIMK1 | 1.29585623 |
38 | JAK3 | 1.29225551 |
39 | VRK1 | 1.29146881 |
40 | LRRK2 | 1.21981333 |
41 | TRIB3 | 1.20856699 |
42 | IKBKB | 1.15759817 |
43 | MYLK | 1.15639103 |
44 | RIPK4 | 1.09435179 |
45 | IRAK3 | 1.07848846 |
46 | BTK | 1.06407931 |
47 | MAP4K2 | 1.04553301 |
48 | MAP3K11 | 1.01596770 |
49 | CDC7 | 0.96704495 |
50 | ADRBK2 | 0.96452091 |
51 | EPHA2 | 0.95875043 |
52 | TSSK6 | 0.95104350 |
53 | ACVR1B | 0.90994245 |
54 | MAP2K2 | 0.90096723 |
55 | LCK | 0.89772017 |
56 | PRPF4B | 0.87195262 |
57 | SCYL2 | 0.85657848 |
58 | CDK19 | 0.83589262 |
59 | LYN | 0.83334017 |
60 | NEK1 | 0.82254946 |
61 | RPS6KA4 | 0.81579887 |
62 | RPS6KB2 | 0.80928878 |
63 | ATR | 0.80284719 |
64 | CCNB1 | 0.79591424 |
65 | PIM1 | 0.79559807 |
66 | SIK3 | 0.76101179 |
67 | CSNK1G3 | 0.75589178 |
68 | MUSK | 0.74563055 |
69 | MST1R | 0.74464063 |
70 | CSF1R | 0.74418512 |
71 | CDK7 | 0.72770435 |
72 | ABL2 | 0.72321384 |
73 | TNK2 | 0.72083643 |
74 | DAPK3 | 0.71951248 |
75 | MAP2K3 | 0.71115635 |
76 | BRAF | 0.70322859 |
77 | PAK1 | 0.68695370 |
78 | CDK8 | 0.68304814 |
79 | PDK2 | 0.65862149 |
80 | CHEK2 | 0.64165895 |
81 | ITK | 0.61452771 |
82 | NLK | 0.60733960 |
83 | SRPK1 | 0.60067093 |
84 | SIK1 | 0.58019834 |
85 | MAP2K6 | 0.57697338 |
86 | BMPR1B | 0.54966099 |
87 | FES | 0.53629902 |
88 | AURKB | 0.51046227 |
89 | MAPK11 | 0.50902163 |
90 | IRAK2 | 0.50754453 |
91 | STK10 | 0.50691913 |
92 | CSK | 0.50045643 |
93 | MAP3K1 | 0.49219787 |
94 | CSNK2A1 | 0.49137527 |
95 | CSNK1A1L | 0.48578825 |
96 | DYRK2 | 0.47797186 |
97 | FLT3 | 0.47547276 |
98 | TAOK3 | 0.46848913 |
99 | BMX | 0.46143973 |
100 | TGFBR1 | 0.46036793 |
101 | PLK1 | 0.45636075 |
102 | STK24 | 0.45449318 |
103 | PIK3CA | 0.44761512 |
104 | CSNK2A2 | 0.44435531 |
105 | PAK4 | 0.44183055 |
106 | CDK4 | 0.43310851 |
107 | MAPKAPK2 | 0.42189593 |
108 | CLK1 | 0.42097345 |
109 | STK4 | 0.41652257 |
110 | PLK4 | 0.41571741 |
111 | MOS | 0.40621988 |
112 | HCK | 0.40406557 |
113 | PRKCQ | 0.40193341 |
114 | MAPKAPK3 | 0.38575795 |
115 | MAP3K3 | 0.38525842 |
116 | PBK | 0.38485527 |
117 | PRKCI | 0.38185820 |
118 | TNIK | 0.38014025 |
119 | AURKA | 0.37836268 |
120 | DAPK1 | 0.37652510 |
121 | CDK9 | 0.37511163 |
122 | RPS6KA5 | 0.37463005 |
123 | PRKCD | 0.36914776 |
124 | GRK5 | 0.36779763 |
125 | DMPK | 0.36592334 |
126 | DYRK3 | 0.35910921 |
127 | STK38L | 0.35790618 |
128 | MATK | 0.34800397 |
129 | MAPK4 | 0.33700021 |
130 | EIF2AK2 | 0.33148209 |
131 | DYRK1B | 0.32788916 |
132 | PRKG2 | 0.31872327 |
133 | MAP3K8 | 0.31078401 |
134 | ADRBK1 | 0.30160114 |
135 | ZAK | 0.28692957 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 5.83923159 |
2 | Proteasome_Homo sapiens_hsa03050 | 4.77183742 |
3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.35866591 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.98816596 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 2.95720921 |
6 | DNA replication_Homo sapiens_hsa03030 | 2.90655409 |
7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.53744133 |
8 | Mismatch repair_Homo sapiens_hsa03430 | 2.28557220 |
9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.25917794 |
10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.09216551 |
11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.04218998 |
12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.03657921 |
13 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.01826910 |
14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.99225008 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.94972324 |
16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.87899681 |
17 | Protein export_Homo sapiens_hsa03060 | 1.87300842 |
18 | Spliceosome_Homo sapiens_hsa03040 | 1.84085660 |
19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.73236773 |
20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.69757520 |
21 | Homologous recombination_Homo sapiens_hsa03440 | 1.68338780 |
22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.66257962 |
23 | Allograft rejection_Homo sapiens_hsa05330 | 1.57375821 |
24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.55911269 |
25 | Base excision repair_Homo sapiens_hsa03410 | 1.52190677 |
26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49355823 |
27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47701692 |
28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44400375 |
29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40407600 |
30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32426125 |
31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30414316 |
32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29709211 |
33 | Measles_Homo sapiens_hsa05162 | 1.29421300 |
34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27535739 |
35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24841679 |
36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.23662657 |
37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.22353156 |
38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18479141 |
39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17004079 |
40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15348835 |
41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14115036 |
42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.12716049 |
43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.10186083 |
44 | RNA transport_Homo sapiens_hsa03013 | 1.08914825 |
45 | Shigellosis_Homo sapiens_hsa05131 | 1.05532017 |
46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03224985 |
47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00747844 |
48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98777732 |
49 | Legionellosis_Homo sapiens_hsa05134 | 0.93110088 |
50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93030452 |
51 | Asthma_Homo sapiens_hsa05310 | 0.92120505 |
52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89088913 |
53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87680043 |
54 | * Purine metabolism_Homo sapiens_hsa00230 | 0.87369412 |
55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84844882 |
56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.83493175 |
57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82194253 |
58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.78608505 |
59 | Pertussis_Homo sapiens_hsa05133 | 0.78290522 |
60 | Salmonella infection_Homo sapiens_hsa05132 | 0.77210127 |
61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75944854 |
62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74410668 |
63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74149762 |
64 | Peroxisome_Homo sapiens_hsa04146 | 0.74054587 |
65 | Apoptosis_Homo sapiens_hsa04210 | 0.70908938 |
66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70125551 |
67 | RNA degradation_Homo sapiens_hsa03018 | 0.69607518 |
68 | Cell cycle_Homo sapiens_hsa04110 | 0.67764585 |
69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.64635531 |
70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64052590 |
71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63424435 |
72 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.63293353 |
73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60685073 |
74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60568457 |
75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59519567 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58742080 |
77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58176568 |
78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57730601 |
79 | Phagosome_Homo sapiens_hsa04145 | 0.57178918 |
80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56903450 |
81 | Tuberculosis_Homo sapiens_hsa05152 | 0.55967922 |
82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55503057 |
83 | Influenza A_Homo sapiens_hsa05164 | 0.54701598 |
84 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53361779 |
85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52271085 |
86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51421104 |
87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50846145 |
88 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50629721 |
89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50479177 |
90 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.49990138 |
91 | Alcoholism_Homo sapiens_hsa05034 | 0.49245870 |
92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49242160 |
93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48583510 |
94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47628427 |
95 | Malaria_Homo sapiens_hsa05144 | 0.44495273 |
96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43960559 |
97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43195915 |
98 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42831426 |
99 | Bladder cancer_Homo sapiens_hsa05219 | 0.40449245 |
100 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.40024112 |
101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39347312 |
102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39315600 |
103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39311843 |
104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38588114 |
105 | Hepatitis B_Homo sapiens_hsa05161 | 0.38238236 |
106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38033471 |
107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37710213 |
108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36326440 |
109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36283186 |
110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35233441 |
111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33656611 |
112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33596821 |
113 | Lysosome_Homo sapiens_hsa04142 | 0.33250347 |
114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32885666 |
115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32584198 |
116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31988632 |
117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31636466 |
118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31516020 |
119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31513393 |
120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30152121 |
121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30101904 |
122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29580086 |
123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29213111 |
124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28357808 |
125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28321053 |
126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27371010 |
127 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25294384 |
128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24680341 |
129 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24619592 |
130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23955511 |
131 | HTLV-I infection_Homo sapiens_hsa05166 | 0.23738919 |